Personnel Information


GEN Yasuyuki

Job title

Assistant Professor

Graduating School 【 display / non-display

  • Kyoto Prefectural University of Medicine, Faculty of Medicine, Graduated

Graduate School 【 display / non-display

  • Kyoto Prefectural University of Medicine, Graduate School, Division of Medicine, Doctor's Course, Completed

Campus Career 【 display / non-display

  • 2016.11
    Tokyo Medical and Dental University, Medical Research Institute, Medical Genomics, Molecular Cytogenetics, Assistant Professor

External Career 【 display / non-display

  • 2010.04
    , Assistant Professor

Research Areas 【 display / non-display

  • Tumor therapeutics

Qualification Acquired 【 display / non-display

  • Doctor


Published Papers & Misc 【 display / non-display

  • Liu C, Gen Y, Tanimoto K, Muramatsu T, Inoue J, Inazawa J. Concurrent targeting of MAP3K3 and BRD4 by <i>miR-3140-3p</i> overcomes acquired resistance to BET inhibitors in neuroblastoma cells. Molecular therapy. Nucleic acids. 2021.09; 25 83-92. ( PubMed, DOI )

  • Gen Y, Muramatsu T, Inoue J, Inazawa J. miR-766-5p targets super-enhancers by downregulating CBP and BRD4. Cancer research. 2021.08; ( PubMed, DOI )

  • Terasaki K, Gen Y, Iwai N, Soda T, Kitaichi T, Dohi O, Taketani H, Seko Y, Umemura A, Nishikawa T, Yamaguchi K, Moriguchi M, Konishi H, Naito Y, Itoh Y, Yasui K. SOX2 enhances cell survival and induces resistance to apoptosis under serum starvation conditions through the AKT/GSK-3β signaling pathway in esophageal squamous cell carcinoma. Oncology letters. 2021.04; 21 (4): 269. ( PubMed, DOI )

  • Takagawa Yuki, Gen Yasuyuki, Muramatsu Tomoki, Tanimoto Kousuke, Inoue Jun, Harada Hiroyuki, Inazawa Johji. miR-1293, a Candidate for miRNA-Based Cancer Therapeutics, Simultaneously Targets BRD4 and the DNA Repair Pathway MOLECULAR THERAPY. 2020.06; 28 (6): 1494-1505. ( PubMed, DOI )

  • Dohi O, Yagi N, Naito Y, Fukui A, Gen Y, Iwai N, Ueda T, Yoshida N, Kamada K, Uchiyama K, Takagi T, Konishi H, Yanagisawa A, Itoh Y. Blue laser imaging-bright improves the real-time detection rate of early gastric cancer: a randomized controlled study. Gastrointestinal endoscopy. 2019.01; 89 (1): 47-57. ( PubMed, DOI )

display all >>

Conference Activities & Talks 【 display / non-display

  • Oligonucleotide therapeutics using a novel tumor-suppressive microRNA targeting MYC pathway. 2020.10.01

  • Yasuyuki Gen, Tomoki Muramatsu, Jun Inoue, Johji Inazawa. Oligonucleotide therapeutics using a novel tumorsuppressive microRNA targeting MYC pathway. 2019.09.28